Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 12 Feb 2025

A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report

in Cancer Immunity and Immunotherapy

Jingjing Chai
Jiaqi Lv
Jian Xiong
Xiuwen Chen
Senyuan Luo
Zhiguo Luo
Ming Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544604

169 views

Review

Published on 12 Feb 2025

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment

in Cancer Immunity and Immunotherapy

Zixuan Xiong
Yichun Huang
Shulong Cao
Xuqun Huang
Haiyuan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1542326

293 views

Original Research

Published on 12 Feb 2025

Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Yan Li
Yean Yu
Kun Lv
Rongjuan Ge
Xie Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557726

134 views

Case Report

Published on 12 Feb 2025

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

in Cancer Immunity and Immunotherapy

Huanhuan Li
Chao Ren
Donghai Cui
Tao Wu
Zhiyong Nie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555074

244 views

Mini Review

Published on 12 Feb 2025

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

in Cancer Immunity and Immunotherapy

Jianyang Ao
Mingtai Hu
Jinghan Wang
Xiaoqing Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559465

449 views

Review

Published on 12 Feb 2025

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

in Cancer Immunity and Immunotherapy

Alberto L. Horenstein
Angelo C. Faini
Fabio Morandi
Erika Ortolan
Paola Storti
Nicola Giuliani
Paul G. Richardson
Fabio Malavasi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519300

246 views

Original Research

Published on 12 Feb 2025

NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

in Cancer Immunity and Immunotherapy

Xuewei Li
Na Wu
Chen Wang
Beibei Pei
Xiaoyan Ma
Jun Xie
Wenhui Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512107

283 views

Systematic Review

Published on 12 Feb 2025

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis

in Cancer Immunity and Immunotherapy

Weiming Liang
Zhijing Wang
Zhilong Huang
Yanping Huang
Chunyan Li
Yiwen Liang
Miaoyan Huang
Duo Zhang
Chenchen Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1430673

232 views

Systematic Review

Published on 12 Feb 2025

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study

in Cancer Immunity and Immunotherapy

Biling Gan
Lei Wu
Shunan Zhou
Zhihong Chen
Fan Wu
Lianqun Xu
Zhenrong Chen
Honghui Ma
Peijia He
Dan Fang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1476146

496 views

Systematic Review

Published on 12 Feb 2025

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review

in Cancer Immunity and Immunotherapy

Xiuyue Man
Hong Wang
Chen Chen
Xiaofeng Cong
Lemeng Sun
Xueru Sun
Chen Chen
Jing Zhang
Lei Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455347

228 views

Original Research

Published on 12 Feb 2025

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis

in Cancer Immunity and Immunotherapy

Daciana C. Dumut
Marian Hajduch
Amanda M. Zacharias
Qingling Duan
Ivo Frydrych
Zuzana Rozankova
Miroslav Popper
Dusan Garic
Radu Alexandru Paun
Amanda Centorame

Frontiers in Immunology

doi 10.3389/fimmu.2025.1491450

677 views

Original Research

Accepted on 11 Feb 2025

Differential neuropilin isoform expressions highlight plasticity in macrophages in the heterogenous TME through in-silico profiling

in Cancer Immunity and Immunotherapy

HYUN-JEE HAN
Marcos Rubio-Alarcon
Thomas Allen
Sunwoo Lee
Taufiq Rahman

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547330

Original Research

Accepted on 11 Feb 2025

Inhibiting Melanoma Tumor Growth: The Role of Oxidative Stress-Associated LINC02132 and COPDA1 Long Non-Coding RNAs

in Cancer Immunity and Immunotherapy

jingwen Xu
mingzhu Jin
zhenzhen Mu
zhengxiu Li
Rui-qun Qi
xiuping Han
hanghang Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558292

Systematic Review

Accepted on 11 Feb 2025

Significant association between systemic inflammation response index and prognosis in patients with urological malignancies

in Cancer Immunity and Immunotherapy

Ma Wangbin
Rongqiang Liu
Xinyi Li
Jia Yu
Weixing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518647

Original Research

Accepted on 11 Feb 2025

Hexokinase2-Engineered T Cells Display Increased Anti-Tumor Function

in Cancer Immunity and Immunotherapy

Raphaëlle Toledano Zur
Shiran Didi Zurinam
Maria Radman
Elia Funaro Balouka
Tatiana Borodianskiy-Shteinberg
Dieter Saur
Cyrille J Cohen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1477929

Mini Review

Accepted on 11 Feb 2025

Tissue-resident memory T cells in urinary tract diseases

in Cancer Immunity and Immunotherapy

Guofeng Xu
Guanting Lu
Daoyuan Xie

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535930

Navigation group

Articles

A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report

A new strategy for the treatment of advanced ovarian cancer: utilizing nanotechnology to regulate the tumor microenvironment

Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy

Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

NALCN expression is down-regulated and associated with immune infiltration in gastric cancer

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis

Differential neuropilin isoform expressions highlight plasticity in macrophages in the heterogenous TME through in-silico profiling

Inhibiting Melanoma Tumor Growth: The Role of Oxidative Stress-Associated LINC02132 and COPDA1 Long Non-Coding RNAs

Significant association between systemic inflammation response index and prognosis in patients with urological malignancies

Hexokinase2-Engineered T Cells Display Increased Anti-Tumor Function

Tissue-resident memory T cells in urinary tract diseases